Infanrix DTPa-IPV+Hib, susp inj 0.5 ml (ancien), ser prê 1 dos
7680006190016
Pharmacode 2065280
CH-619
J07CA06
1 / 2
google
Details
- GTIN
- 7680006190016
- Pharmacode
- 2065280
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum diphtheriae
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
lactosum
|
- | Substance | HNIDK |
|
toxoidum tetani
|
- | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
toxoidum pertussis
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
haemagglutininum filamentosum
|
25.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
pertactinum
|
8.0 UG | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 1 inactivatus
|
40.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 2 inactivatus
|
8.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 U | Substance | Wirkstoff (Principe actif) |
|
virus poliomyelitis typus 3 inactivatus
|
32.0 U | Substance | Wirkstoff (Principe actif) |
|
polysaccharida haemophili influenzae typus B 20752 conjugata cum toxoido tetani
|
10.0 UG | Substance | Wirkstoff (Principe actif) |
|
aluminium
|
0.5 MG | Substance | HBESI |
|
aluminium
|
0.5 MG | Substance | HBESI |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
aluminii hydroxidum hydricum ad adsorptionem
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
medium 199
|
- | Substance | HNIDK |
|
natrium
|
1.8 MG | Substance | HBESI |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
medium 199
|
- | Substance | HNIDK |
|
lactosum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
neomycini sulfas
|
- | Substance | RESI |
|
polymyxini B sulfas
|
- | Substance | RESI |
|
neomycini sulfas
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
|
polymyxini B sulfas
|
- | Substance | RESI |
|
polysorbatum 80
|
- | Substance | RESI |
|
formaldehydum
|
- | Substance | RESI |
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 619
- Drug name
- Infanrix DTPa-IPV+Hib, Pulver und Suspension zur Herstellung einer Injektionssuspension
- Galenic form
- PULSIN
- ATC Code
- J07CA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 29/09/1998
- Authorization expiration date
- 31/12/9999
- IT number
- 08.08.
- Domain
- Human medicine
Packaging details
- Description (FR)
- INFANRIX DTPa-IPV+Hib susp inj ser pré 0.5 ml
- Description (DE)
- INFANRIX DTPa-IPV+Hib Inj Susp Fertspr 0.5 ml
- Narcotic (BTM)
- No
Application methods
IMU